On December 1st, the first batch of cyclotrons produced by General Electric Medical China (GE Medical China) in the United States was unveiled at the Tianfu International Biotech City in Chengdu.
GE Healthcare is a global leader in precision healthcare innovation. In January of this year, it was spun off from the Fortune 500 company GE Group and successfully listed on NASDAQ in the United States. Its business scope covers four major sectors: medical imaging, ultrasound, life care, and diagnostic drugs.
The first batch of cyclotron offline ceremony was successfully held in Chengdu Tianfu International Biological City, marking the landing of efficient service projects in the park and achieving phased results in accelerating project implementation. With the smooth progress of the project, more upstream and downstream supporting enterprises and precision medical partner projects of GE Medical will be accelerated to settle in the park, helping Chengdu's precision medical industry build a strong chain and attracting more globally renowned high-energy chain owners Enterprises are accelerating their gathering The person in charge of Chengdu Tianfu International Biological City stated.
GE Healthcare Investment in Chengdu
In recent years, GE Healthcare has accelerated its layout in western China. In October 2022, the GE Medical High Energy Industry Project signed a contract and landed in Chengdu High tech Zone, and was launched in May of this year at Chengdu Tianfu International Biological City. The first phase focuses on the production and manufacturing of key equipment for nuclear medicine molecular imaging - cyclotrons, promoting the innovative development of the precision medical industry chain with nuclear medicine imaging equipment as the core, and deeply participating in the high-quality development of the health and health industry in the dual city economic circle of western China and the Chengdu Chongqing region.
It is reported that nuclear medicine is an emerging discipline in modern medicine, playing a crucial role in precision medicine. The cyclotron is a key equipment in the integrated precision diagnosis and treatment solution of nuclear medicine. It combines chemical synthesis equipment, SPECT/CT, PET/CT (MR), software and hardware, etc., to form GE Medical's One MI molecular imaging integrated clinical research solution. This plan forms a complete closed-loop nuclear medicine ecosystem from nuclide production, drug synthesis, image data collection to drug application, and matching nuclides. It predicts the molecular status of diseases more early and accurately, allowing clinical patients to discover earlier lesions and develop personalized diagnosis and treatment plans, assisting clinical research in overcoming major diseases such as neurology, oncology, and cardiology.
The foundation of precision medicine is precision diagnosis, and molecular imaging in nuclear medicine is the core to achieve precision diagnosis. GE Medical attaches great importance to the opportunities of China's western development, and increases cooperation in medical technology innovation, high-end equipment manufacturing, and modern service hub construction, promoting the innovative and integrated development of nuclear medicine high-end equipment, precision medicine industry chain, and supply chain, and supporting the Healthy Sichuan Action Strategy to quickly respond to new medical infrastructure construction The demand for nuclear medicine technology equipment provides services for precise diagnosis and treatment of doctors and patients Chen Heqiang, Vice President of GE Healthcare China and General Manager of China Supply Chain, stated.
The upstream news has learned that GE Healthcare China will also promote the second phase plan in the future, relying on the advantages of Chengdu's "the Belt and Road" node city and precision medical industry ecosystem, jointly build innovation centers and cooperation centers with partners, and introduce multiple upstream, downstream and industrial ecosystem partners to build industrial clusters and build a reliable, safe and resilient local supply chain system.
